Wyeth-Lederle pneumococcal vaccine
Executive Summary
FDA's Vaccines & Related Biological Products Advisory Committee will review Wyeth's PLA for the pneumococcal 7-valent conjugate vaccine on Nov. 5. The committee will assess the safety and efficacy of the vaccine for prevention of invasive disease (bacteremia and meningitis) caused by Streptococcus pneumoniae